|
Contents of Volume 5 Suppl 2
1st Workshop of the International Society for Behçet's Disease (ISBD) on Pathophysiology and Treatment of Behçet's Disease
Meeting abstracts
Kühtai, Austria. 2  5 April 2003
Edited by S Assaad-Khalil, H Direskeneli, M Schirmer
This workshop was supported in part by Merck Austria and the Scientific Society of Hematology, Oncology and Immunology, Innsbruck Austria
|
Meeting abstract
Introduction
CG Barnes
Arthritis Res Ther 2003, 5(Suppl 2):1 (9 September 2003)
[Full text] [PDF] [PubMed] [Related articles]
Meeting abstract
Perspectives of the Working Group on Drug Trials including Collaborative Trials of the ISBD and rationale for new clinical trials
S Assaad-Khalil
Arthritis Res Ther 2003, 5(Suppl 2):2 (9 September 2003)
[Full text] [PDF]
Meeting abstract
Cytotoxic drugs in ocular lesions of Behçet's disease
F Davatchi, F Shahram, H Chams, A Nadji, AR Jamshidi, C Chams, M Akbarian, F Gharibdoost, M Sedigh, B Sadeghi
Arthritis Res Ther 2003, 5(Suppl 2):3 (9 September 2003)
[Full text] [PDF]
Meeting abstract
The use of interferon-alfa in Behçet's disease: review of the literature
I Kötter, I Günaydin, M Zierhut, N Stübiger
Arthritis Res Ther 2003, 5(Suppl 2):4 (9 September 2003)
[Full text] [PDF]
Meeting abstract
Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four center trial
I Kötter, M Treusch, R Vonthein, M Zierhut, A Eckstein, T Ness, I Günaydin, B Grimbacher, S Blaschke, HH Peter, N Stübiger
Arthritis Res Ther 2003, 5(Suppl 2):5 (9 September 2003)
[Full text] [PDF]
Meeting abstract
TNF and anti-TNF agents in Behçet's disease
KT Calamia
Arthritis Res Ther 2003, 5(Suppl 2):6 (9 September 2003)
[Full text] [PDF]
Meeting abstract
A review on disease activity scores in Behçet's disease (BD)
M Baltaci
Arthritis Res Ther 2003, 5(Suppl 2):7 (9 September 2003)
[Full text] [PDF]
Meeting abstract
Behçet's disease: from innate to adaptive immunity
H Direskeneli
Arthritis Res Ther 2003, 5(Suppl 2):8 (9 September 2003)
[Full text] [PDF]
Meeting abstract
Migration of dendritic cells into the lymphatics: the Langerhans cell example
N Romani, P Stoitzner, S Ebner, H Stössel, S Holzmann, G Ratzinger, P Fritsch
Arthritis Res Ther 2003, 5(Suppl 2):9 (9 September 2003)
[Full text] [PDF]
Meeting abstract
Viral infection of retinal pigment epithelium: a possible role for initiation of Behçet's disease
EU Irschick, HP Huemer, C Larcher, R Sgonc, W Göttinger
Arthritis Res Ther 2003, 5(Suppl 2):10 (9 September 2003)
[Full text] [PDF]
Meeting abstract
Regulation of inflammatory CD28- T-helper cells by HLA class I molecules: a new cellular model for Behçet's disease?
C Duftner, C Goldberger, E Märker-Hermann, M Schirmer
Arthritis Res Ther 2003, 5(Suppl 2):11 (9 September 2003)
[Full text] [PDF]
Meeting abstract
Immunosuppressive effects of gemcitabine in the HSV-induced Behçet's disease like mouse model
S Sohn, M Lutz, HJ Kwon, G Konwalinka, S Lee, M Schirmer
Arthritis Res Ther 2003, 5(Suppl 2):12 (9 September 2003)
[Full text] [PDF]
Meeting abstract
Streptococcal antigen in the pathogenesis of Behçet's disease
F Kaneko, H Yanagihori, M Tojo, E Isogai, SN Lin, K Oguma
Arthritis Res Ther 2003, 5(Suppl 2):13 (9 September 2003)
[Full text] [PDF]
|
